Richard Podell, M.D., MPH, is a Clinical Professor at Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey and had a private practice where he saw ME/CFS, Fibromyalgia and other patients. He practiced integrated medicine in Summit, NJ but is retired as of September 1, 2017. He was a provider of Ampligen during one of its earlier trials.
In 2002, Podell was a member of the writing committee for A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome, a clinical care manual produced by The Academy of Medicine of New Jersey and the New Jersey Department of Health and Senior Services.
Dr. Podell provides updates in research and treatment options via his YouTube channel: Chronic Fatigue and Fibromyalgis Update with Dr. Richard Podell
Education[edit | edit source]
- M.D. - Harvard Medical School
Writing committees[edit | edit source]
- 2002, Dr. Podell was on the writing committee for A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome, Joseph F. John, Jr., MD, Editor and James M. Oleske, MD, MPH, Associate Editor.
Advocacy[edit | edit source]
Open Letter to The Lancet[edit | edit source]
Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Podell, along with 41 colleagues in the ME/CFS field, signed the second letter.
- 10 February 2016, An open letter to The Lancet, again - Virology blog
Talks and interviews[edit | edit source]
Chronic Fatigue and Fibromyalgis Update with Dr. Richard Podell[edit | edit source]
- Ginevra Liptan - Segment 1: The Pros and Cons of medical Marijuana Use of Fibromyalgia Patients
- Ginevra Liptan - Segment 2: The Use of Medical Marijuana for Fibromyalgia Patients
- Kim Jones - Segment 1: Exercise with Fibromyalgia
- Kim Jones - Segment 2: Exercise and Fibromyalgia
- Kim Jones - Segment 3: Exercise and Fibromyalgia
- Alan Light - Segment 1: Why Research Chronic Fatigue Syndrome and Fibromyalgia?
- Alan Light - Segment 2: Detailed Explanation of Dr. Light's CFS and FM Research
- Alan Light - Segment 3: Update on Dr. Light's Recent CFS and FM Research
Studies and articles[edit | edit source]
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study - (Full Text)
- 2019, Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases
Online presence[edit | edit source]
References[edit | edit source]
- John, Joseph F.; Oleske, James, eds. (2002). A Consensus Manual for the Primary Care and Management of Chronic Fatigue Syndrome. New Jersey: The Academy of Medicine of New Jersey, The New Jersey Department of Health & Senior Services.
- Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
- Comerford, Barbara B.; Podell, Richard (Jul 2, 2019). "Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases". Frontiers in Pediatrics. 7: 231. doi:10.3389/fped.2019.00231. ISSN 2296-2360. PMC . PMID 31334205.
Myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.